Facebook
X
LinkedIn
Forward
MGB Glomerular Disease Conference 2026
This is a live activity.
The 1-Day Glomerular Disease Conference will bring together clinicians and researchers to discuss recent advances in the understanding and management of glomerular diseases. The program will highlight emerging therapeutic strategies, clinical trial updates, and practical considerations for incorporating new agents into patient care. Sessions will include expert lectures, interactive case discussions, and debates. The conference aims to provide attendees with up-to-date, actionable insights that bridge science and clinical practice.
Target Audience
This activity is intended for nephrologists and other health care professionals (physicians, physician assistants, nurses, nurse practitioners, and administrators) taking care of patients with autoimmune and rare kidney disease.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify and interpret recent evidence-based clinical trials in glomerular diseases and their impact on treatment strategies.
- Apply current data to the use of novel immunologic and complement-targeted therapies in clinical practice.
- Apply personalized approaches and nuanced decision-making to optimize patient outcomes in glomerular disease management.
Additional Information
Please join us on Friday, May 29th, 2026 for pre-conference events:
- 4:00-5:15pm Patient Forum (in partnership with the IgAN Foundation)
- 6:00-7:00pm Welcome Reception
Saturday, May 30, 2026
| 7:50am | Welcome & Opening Remarks Ayman Al Jurdi, MD & Harish Seethapathy, MD |
| 8:00 | Keynote Talk Glomerular Disease Therapy Through Time - Lessons from the Past, Vision for the Future John Niles |
| 8:30 | IgA Odyssey: Defining the Present, Imagining the Future Harish Seethapathy, MD |
| 9:00 | Panel Discussion Integrating New Therapeutics into Practice for IgA Nephropathy: Should Everyone Receive B-Cell Modulation & Foundational Therapies? Moderators: Harish Seethapathy, MD & Purva Sharma Panelists: Andrew Bomback, Michael Walsh, Purva Sharma, Ali Poyan Mehr & Gaia Coppack |
| 9:45 | Coffee Break & Networking |
| 10:00 | Are We There Yet? Rethinking Therapy Success in ANCA Vasculitis & Membranous Nephropathy / Panel + Q&A Andrew Bomback & Michael Walsh |
| 11:15 | Podocytopathies Astrid Weins & Ayman Al Jurdi, MD |
| 12:00pm | Lunch Break & Networking |
| 12:30 | Lunch Talk: Role of GlomCon & Implementation of New Therapies Ali Poyan Mehr |
| 1:00 | Lupus Nephritis Management: Is B-Cell Depletion Now the Cornerstone of Management? Panel + Q&A Speaker: Meghan Sise, MD Panelists: Meghan Sise, MD, Gaia Coppack, David Mount & John Niles |
| 2:00 | Concurrent Sessions Genetics Workshop with Rare Glomerular Diseases & Emerging Therapies Rapid Fire Case Discussion Speaker: Andrew Lundquist Moderator: Orhan Efe Case Presenters: Janewit Wongboonsin, Orhan Efe & Ana Onuchic-Whitford Nursing & Administrator Forum: Illustration of Resources Available to Patients Speaker/Moderator TBD |
| 3:30 | Coffee Break |
| 3:45 | Clinical Pearls/Case Studies of Mass General Brigham Panelists: David Mount, Ayman Al Jurdi, MD & Ashima Chaddha |
| 4:30 | Panel Discussion: Hot Takes in Glomerular Disease Treatment Moderator TBD Panelists: Purva Sharma, Gaia Coppack, Michael Walsh, Meghan Sise, MD & John Niles |
| 5:15 | Closing Remarks & Takeaways Harish Seethapathy, MD & Ayman Al Jurdi, MD |
| 5:30pm | Adjournment |
Accommodations
The Row Hotel is offering a special group rate for attendees:
- The Row Hotel at Assembly Row, Autograph Collection for 259.00 USD per night (subject to availability)
- Last Day to Book: Thursday, April 30, 2026
Conference Co-Directors
Harish Seethapathy, MD
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Massachusetts General Hospital
Ayman Al Jurdi, MD
Assistant Professor of Medicine, Harvard Medical School
Assistant in Medicine, Massachusetts General Hospital
Faculty
John Niles, MD
Associate Professor of Medicine, Harvard Medical School
Director, Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital
Andrew Bomback, MD, MPH
Associate Professor of Medicine, Columbia University Irving Medical Center
Co-Director, Center for Glomerular Diseases, Columbia University Irving Medical Center
Michael Walsh, MD, PhD
Professor of Medicine, McMaster University
Scientist, Population Health Research Institute
Lead, Glomerulonephritis Registry and Research
Ali Poyan Mehr, MD
Founding President, GlomCon Foundation
Director of the Regional Glomerular Disease Program, Kaiser Permanente - Northern California
Gaia Coppock, MD
Assistant Professor of Clinical Medicine, Perelman School of Medicine
Director, Glomerular Disease Clinical Research Program and Lupus Nephritis Program, Hospital of the University of Pennsylvania
Purva Sharma, MD
Assistant Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Co-Director of the Glomerular Disease Center, Donald and Barbara Zucker School of Medicine at Northwell
David Mount, MD
Associate Professor of Medicine, Harvard Medical School
Clinical Director, Renal Division, Brigham and Women’s Hospital
Andrew Lundquist, MD, PhD
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Massachusetts General Hospital
Co-Director of Renal Genetics, Mass General Brigham
Meghan Sise, MD, MS
Associate Professor of Medicine, Harvard Medical School
Director, Onco-Nephrology Program, Massachusetts General Hospital
Orhan Efe, MD
Assistant Professor of Medicine, Harvard Medical School
Assistant in Medicine, Massachusetts General Hospital
Ashima Chaddha, MD
Clinical and Research Fellow, Mass General Brigham Vasculitis and Glomerulonephritis Center
Janewit Wongboonsin, MD
Instructor of Medicine, Harvard Medical School
Nephrologist, Brigham and Women’s Hospital
Ana Onuchic-Whitford, MD
Assistant Professor of Medicine, Harvard Medical School
Co-Director of Renal Genetics, Mass General Brigham
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC RECOGNITION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 6.00 ABIM Medical Knowledge
- 6.00 AMA PRA Category 1 Credit™
- 6.00 Participation
Please note: exhibit and commercial support activities are separate from the educational content of this course. Exhibitors have no influence over the planning, content, or faculty of this educational activity.
Our Sponsors:
Price
| Registration Type | Tuition Fee |
|---|---|
| In-Person Healthcare Professional (MD, PA, RN, NP, Administrators) | $100 |
| In-Person Industry Learner Limited to three (3) per company | $100 |
| In-Person Trainee | $100 |
| Virtual Healthcare Professional (MD, PA, RN, NP, Administrators) | $100 |
| Virtual Industry Learner Limited to three (3) per company | $100 |
| Virtual Trainee | $100 |
Cancellation Policy:
Registrations cancelled on or before May 16, 2026 will be refunded, less a $15 administrative fee. Registrations cancelled after May 16, 2026 will not be refunded.
Contact Maxine Harney if you require assistance in cancelling your online registration.